Providing New Answers in Women’s Health Through Unique Delivery Technology
FemmePharma Global Healthcare is leveraging its proprietary delivery technology platforms to fulfill unmet needs in a variety of women’s health conditions. Here are just a few areas in which we are designing solutions specifically for women in order to make their lives better.
This disorder occurs when tissue that normally lines the inside of the uterus, called the endometrium, grows outside of the uterus. It can cause pain, sometimes severe, during menstruation, and can affect fertility. Treatment options include over-the-counter pain relievers, prescription hormone therapy, or even surgery, all of which have obvious drawbacks.
Pain Associated with Fibrocystic Breast Disease (FBD)
There are about 26 million women in the U.S. today with FBD, an often painful condition with limited options for symptomatic relief beyond chronic use of NSAIDs, and a short-term prescription therapy burdened with many side effects. Patients report that FBD pain is a serious problem that interferes with their sexual and physical activities, as well as work.
This condition, also known as Overactive Bladder or OAB, affects more than 20 million women in this country, and has significant lifestyle implications. Current therapies include oral anticholinergics and antispasmodics that are only marginally effective and are associated with a variety of unpleasant side effects.
FemmePharma will soon deliver effective, women-friendly solutions to these challenging health problems. To learn more, please click the button below.